Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 25, 2017
Pharmacy Choice - News - Drug Delivery Systems - June 25, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 88     Next >>     Go To Page:

6/24/17 - Alcyone Lifesciences, Lowell, Mass., Assigned Patent for Drug Delivery Systems
Alcyone Lifesciences, Lowell, Massachusetts, has been assigned a patent developed by four co-inventors for "drug delivery systems and methods." The co-inventors are P.J. Anand, Lowell, Massachusetts, Morgan Brophy, Somerville, Massachusetts, Deep Arjun Singh, Cambridge, Massachusetts, and Greg Eberl, Acton, Massachusetts. Written by Amal Ahmed; edi
6/24/17 - Bristol-Myers Squibb Announces Availability of New ORENCIA abatacept Subcutaneous Administration Option for Patients 2 Years of Age and Older with...
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Bristol-Myers Squibb Company announced the availability of a new FDA- approved subcutaneous ORENCIA administration option for use in patients 2 years of age and older with moderately to severely active polyarticular Juvenile Idiopathic Arthritis. 1 The new prefilled syringe o
6/24/17 - Genentechs subcutaneous rituximab approved in US [Sport360]
With cheaper biosimilars of the original Rituxan formulation edging closer to the US market, Genentechs owner Roche is looking for ways to maintain sales. Rituximab biosimilars have already been approved in Europe, where the subcutaneous formulation was approved last year. The FDA noted that the US label will include the following previously approv
6/24/17 - Indivior Presents Phase III data on Potential Drug for Opioid Use Disorder [T-break Tech (Middle East)]
Indivior PLC announced the presentation of results from its pivotal Phase 3 clinical trial evaluating the efficacy and safety of RBP-6000, an investigational once-monthly injectable buprenorphine in the ATRIGEL delivery system for the treatment of adults with moderate-to-severe opioid use disorder as part of a complete treatment plan to include...
6/24/17 - Roches Top-Selling Cancer Drug Approved in Faster Injection Form [T-break Tech (Middle East)]
The U.S. Food and Drug Administration approved Rituxan Hycela for subcutaneous injection. The FDA approval is for the treatment of adults with three blood cancers: previously untreated or relapsed or refractory follicular lymphoma, previously untreated diffuse large B-cell lymphoma, and previously treated chronic lymphocytic leukemia.
6/24/17 - University of Massachusetts, Boston, Assigned Patent for Drug Delivery Product
The University of Massachusetts, Boston, has been assigned a patent developed by Gary R. Ostroff, Worcester, Massachusetts, for "drug delivery product and methods." The patent application was filed on Nov. 6, 2013. Written by Amal Ahmed; edited by Sudarshan Harpal.
6/23/17 - Advanced Infusion Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 20162024
The key factors that are driving the advanced infusion systems market are the overall growth in the global population that are suffering from diabetes, cancer, and chronic disease.Sarasota, FL 06/22/2017 Zion Market Research, the market research group announced the analysis report titled " Advanced Infusion Systems Market: Global Industry Ana
6/23/17 - Data from Singapore National University Provide New Insights into Drug Delivery Systems (Directing Assembly and Disassembly of 2D MoS2 Nanosheets...
By a News Reporter-Staff News Editor at Drug Week Researchers detail new data in Drugs and Therapies- Drug Delivery Systems. According to news reporting originating in Singapore, Singapore, by NewsRx journalists, research stated, "Layer-by-layer self-assembled stacked Testudo-like MoS2 superstructures carrying cancer drugs are formed from nanoshe
6/23/17 - European CHMP Adopts Positive Opinion For Gilead Sciences' Vosevi
FOSTER CITY- Gilead Sciences Inc. said that the Committee for Medicinal Products for Human Use or CHMP, the scientific committee of the European Medicines Agency or EMA, has adopted a positive opinion on the company's Marketing Authorization Application or MAA for Vosevi, an investigational, once-daily, single tablet regimen of sofosbuvir 400 mg,..
6/23/17 - European CHMP Adopts Positive Opinion for Gilead's Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Chronic Hepatitis C Genotypes
Gilead Sciences, Inc. today announced that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has adopted a positive opinion on the company s Marketing Authorization Application for Vosevi , an investigational, once-daily, single tablet regimen of sofosbuvir 400 mg, velpatasvir 100 mg
6/23/17 - FDA approves Rituxan Hycela (rituximab and hyaluronidase human) for subcutaneous injection in certain blood cancers
Basel Roche announced today that the US Food and Drug Administration approved Rituxan Hycela (TM) for subcutaneous injection, for the treatment of adults with the following blood cancers: previously untreated and relapsed or refractory follicular lymphoma, previously untreated diffuse large B-cell lymphoma, and previously untreated and previously
6/23/17 - Findings on Drug Delivery Systems Detailed by Researchers at Wuhan University of Science and Technology (Self-assembly of DNA-based Nanomaterials and...
Findings on Drug Delivery Systems Detailed by Researchers at Wuhan University of Science and Technology. According to news reporting out of Wuhan, People's Republic of China, by NewsRx editors, research stated, "DNA can be self-assembled into programmable two-dimensional and three-dimensional nanoarchitectures with arbitrarily predetermined sizes..
6/23/17 - June 26-29: The University of Tennessee Health Science Center Designated Center of Excellence in Global Pharmaceutical Supply Chain Security, Hosts In
Dr. Brown is leading the development of the new Plough Center for Sterile Drug Delivery Systems at UTHSC, a $16 million pharmaceutical manufacturing facility opening late this summer. He has made presentations in China, the Philippines, Peru, and elsewhere to senior officials of APEC about the university's desire to be involved in the global effort
6/23/17 - New Data at EAN Show Genentech's Ocrevus (Ocrelizumab) Significantly Reduced Multiple Measures of Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis
Genentech, a member of the Roche Group, announced today that new post-hoc analyses from the OCREVUS TM Phase III clinical trial program in people with relapsing and primary progressive forms of multiple sclerosis will be presented at the 3rd Congress of the European Academy of Neurology from June 24 to June 27 in Amsterdam, Netherlands. OCREVUS sig
6/23/17 - New Drug Delivery Systems Findings Has Been Reported by Investigators at Department of Pediatrics (Drug Delivery in Asthmatic Children Following...
New Drug Delivery Systems Findings Has Been Reported by Investigators at Department of Pediatrics. According to news reporting originating in Little Rock, Arkansas, by NewsRx journalists, research stated, "Valved holding chambers are used in children to deliver pressurized metered dose inhalers. The news reporters obtained a quote from the research
6/23/17 - New Findings from Indian Institute of Technology Describe Advances in Drug Delivery Systems (Wavelength Dependent, Sequentially Activated, Dual...
According to news originating from Kharagpur, India, by NewsRx correspondents, research stated, "Development of new photoresponsive drug delivery systems for combination chemotherapy is sought-after due to their precise spatio-temporal control over delivering drugs. Our news journalists obtained a quote from the research from the Indian Institute o
6/23/17 - OncoSynergy, Infuseon Therapeutics partner to combat glioblastoma [T-break Tech (Middle East)]
Infuseon Therapeutics and OncoSynergy have entered into a strategic alliance to test an investigational glioblastoma therapeutic, OS2966, in combination with a novel delivery device, the Cleveland Multiport Catheter. Despite a median survival of merely 12 months, there have been only four FDA approved therapies and no improvement in overall surviva
6/23/17 - Patent Issued for Drug Delivery Device and Set of a Drug Delivery Device and a Plurality of Mountable Elements (USPTO 9669202)
By a News Reporter-Staff News Editor at Drug Week A patent by the inventors Smith, Christopher; Ekman, Matthew, filed on July 2, 2010, was published online on June 6, 2017, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9669202 is assigned to SANOFI-AVENTIS DEUTSCHLAND GMBH. The followin
6/23/17 - Patent Issued for Safety Device and Injection Device (USPTO 9669170)
By a News Reporter-Staff News Editor at Drug Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Ekman, Matthew; Smith, Christopher James; Baker, Troy; Wilson, Graham; Roberts, Gareth; Tucker, Carl, filed on September 11, 2012, was published online on June 6, 2017. The patent's assignee for patent number 96691
6/23/17 - ProLynx collaborates with Daiichi Sankyo on drug delivery [Tehran Times (Iran)]
ProLynx is to collaborate with international pharmaceutical company Daiichi Sankyo Co to evaluate its drug delivery linker technology in the eye. Daniel Santi, co-founder and President of ProLynx, said: There are numerous opportunities for our half-life extension technology in localised delivery of drugs. Based in San Francisco, CA, ProLynx is a pr
6/23/17 - Reports from University of Tampere Advance Knowledge in Drug Delivery Systems (Biocompatibility of Liposome Nanocarriers in the Rat Inner Ear After...
Reports from University of Tampere Advance Knowledge in Drug Delivery Systems. According to news reporting from Tampere, Finland, by NewsRx journalists, research stated, "Liposome nanocarriers are potentially the future of inner ear therapy due to their high drug loading capacity and efficient uptake in the inner ear after a minimally invasive...
6/23/17 - Researchers from Virginia Commonwealth University Detail Findings in Drug Delivery Systems (Aerosol Drug Delivery During Noninvasive Positive...
By a News Reporter-Staff News Editor at Drug Week Data detailed on Drugs and Therapies- Drug Delivery Systems have been presented. According to news reporting from Richmond, Virginia, by NewsRx journalists, research stated, "Nebulized aerosol drug delivery during the administration of noninvasive positive pressure ventilation is commonly implemen
6/23/17 - Studies from Zhengzhou University Have Provided New Data on Nanoparticles (IONP-doped nanoparticles for highly effective NIR-controlled drug release...
By a News Reporter-Staff News Editor at Drug Week Current study results on Nanotechnology- Nanoparticles have been published. According to news reporting from Zhengzhou, People's Republic of China, by NewsRx journalists, research stated, "Despite advances in controlled drug delivery, drug delivery systems with controlled activated drug release an
6/23/17 - US FDA approves Glenmark Pharma`s drug for overactive bladder [Sudan Tribune]
Glenmark Pharmaceuticals on Thursday said the US health regulator has granted tentative approval for tablets used for treatment of overactive bladder. The company has been granted tentative approval by the United States Food and Drug Administration for Solifenacin Succinate tablets, 5 mg and 10 mg, Glenmark Pharmaceuticals said in a BSE filing.
6/23/17 - Virginia business briefs for June 23 hammer
Richmond- based pharmaceutical company Kalo has donated 250,000 Evzio auto-injectors since it launched its Kalo product donation program in October 2014. Richmond- based Dominion Energy's Kewaunee Power Station in Wisconsin achieved a milestone on Saturday when employees working to permanently decommission the facility transported the last of..
Articles(s): 1 - 25 of 88     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415